Massimo Tortarolo

Massimo Tortarolo

Auto-generated profile, based on publicly available information

Massimo Tortarolo

Research Center for ALS, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MBManuela Basso
Manuela Basso
SPSilvia Pozzi
Silvia Pozzi
MTMassimo Tortarolo
Massimo Tortarolo
FFFabio Fiordaliso
Fabio Fiordaliso
CBCinzia Bisighini
Cinzia Bisighini
VBValentina Bonetto
Valentina Bonetto
Amyotrophic lateral sclerosis is the most common motor neuron disease and is still incurable. The mechanisms leading to the selective motor neuron vulnerability are still not known. The interplay between motor neurons and astrocytes is crucial in the outcome of the disease. We show that mutant copper-zinc superoxide dismutase (SOD1) overexpression in primary astrocyte cultures is associated with decreased levels of proteins involved in secretory pathways. This is linked to a general reduction of total secreted proteins, except for specific enrichment in a number of proteins in the media, such as mutant SOD1 and valosin-containing protein (VCP)/p97. Because there was also an increase in exosome release, we can deduce that astrocytes expressing mutant SOD1 activate unconventional secretory pathways, possibly as a protective mechanism. This may help limit the formation of intracellular aggregates and overcome mutant SOD1 toxicity. We also found that astrocyte-derived exosomes efficiently transfer mutant SOD1 to spinal neurons and induce selective motor neuron death. We conclude that the expression of mutant SOD1 has a substantial impact on astrocyte protein secretion pathways, contributing to motor neuron pathology and disease spread.

15 November 2001 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
CBCaterina Bendotti
Caterina Bendotti
MTMassimo Tortarolo
Massimo Tortarolo
SSSachin K. Suchak
Sachin K. Suchak
NCNovella Calvaresi
Novella Calvaresi
LCLucia Carvelli
Lucia Carvelli
TMTiziana Mennini
Tiziana Mennini
Glutamate‐induced excitotoxicity is suggested to play a central role in the development of amyotrophic lateral sclerosis (ALS), although it is still unclear whether it represents a primary cause in the cascade leading to motor neurone death. We used western blotting, immunocytochemistry and in situ hybridization to examine the expression of GLT‐1 in transgenic mice carrying a mutated (G93A) human copper–zinc superoxide dismutase (TgSOD1 G93A), which closely mimic the features of ALS. We observed a progressive decrease in the immunoreactivity of the glial glutamate transporter (GLT‐1) in the ventral, but not in the dorsal, horn of lumbar spinal cord. This effect was specifically found in 14‐ and 18‐week‐old mice that had motor function impairment, motor neurone loss and reactive astrocytosis. No changes in GLT‐1 were observed at 8 weeks of age, before the appearance of clinical symptoms. Decreases in GLT‐1 were accompanied by increased glial fibrillary acidic protein (GFAP) levels and no change in the levels of GLAST, another glial glutamate transporter. The glutamate concentration in the cerebrospinal fluid (CSF) of TgSOD1 G93A mice was not modified at any of the time points examined, compared with age‐matched controls. These findings indicate that the loss of GLT‐1 protein in ALS mice selectively occurs in the areas affected by neurodegeneration and reactive astrocytosis and it is not associated with increases of glutamate levels in CSF. The lack of changes in GLT‐1 at the presymptomatic stage suggests that glial glutamate transporter reduction is not a primary event leading to motor neurone loss.

1 June 2003 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
MTM Tortarolo
M Tortarolo
Pietro VeglianesePietro Veglianese
Pietro Veglianese
NCN Calvaresi
N Calvaresi
ABA Botturi
A Botturi
CRC Rossi
C Rossi
CBCaterina Bendotti
Caterina Bendotti

29 September 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
CCCristina Cheroni
Cristina Cheroni
MMMarianna Marino
Marianna Marino
MTMassimo Tortarolo
Massimo Tortarolo
Pietro VeglianesePietro Veglianese
Pietro Veglianese
SBSilvia De Biasi
Silvia De Biasi
CBCaterina Bendotti
Caterina Bendotti
In familial and sporadic amyotrophic lateral sclerosis (ALS) and in rodent models of the disease, alterations in the ubiquitin-proteasome system (UPS) may be responsible for the accumulation of potentially harmful ubiquitinated proteins, leading to motor neuron death. In the spinal cord of transgenic mice expressing the familial ALS superoxide dismutase 1 (SOD1) gene mutation G93A (SOD1G93A), we found a decrease in constitutive proteasome subunits during disease progression, as assessed by real-time PCR and immunohistochemistry. In parallel, an increased immunoproteasome expression was observed, which correlated with a local inflammatory response due to glial activation. These findings support the existence of proteasome modifications in ALS vulnerable tissues. To functionally investigate the UPS in ALS motor neurons in vivo, we crossed SOD1G93A mice with transgenic mice that express a fluorescently tagged reporter substrate of the UPS. In double-transgenic UbG76V-GFP /SOD1G93A mice an increase in UbG76V-GFP reporter, indicative of UPS impairment, was detectable in a few spinal motor neurons and not in reactive astrocytes or microglia, at symptomatic stage but not before symptoms onset. The levels of reporter transcript were unaltered, suggesting that the accumulation of UbG76V-GFP was due to deficient reporter degradation. In some motor neurons the increase of UbG76V-GFP was accompanied by the accumulation of ubiquitin and phosphorylated neurofilaments, both markers of ALS pathology. These data suggest that UPS impairment occurs in motor neurons of mutant SOD1-linked ALS mice and may play a role in the disease progression.

1 December 2005 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
MTMassimo Tortarolo
Massimo Tortarolo
GGGiuliano Grignaschi
Giuliano Grignaschi
NCNovella Calvaresi
Novella Calvaresi
EZEleonora Zennaro
Eleonora Zennaro
GSGabriella Spaltro
Gabriella Spaltro
CBCaterina Bendotti
Caterina Bendotti

1 February 2006 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
Pietro VeglianesePietro Veglianese
Pietro Veglianese
DCD. Lo Coco
D. Lo Coco
MCM. Bao Cutrona
M. Bao Cutrona
RMR. Magnoni
R. Magnoni
DPD. Pennacchini
D. Pennacchini
CBCaterina Bendotti
Caterina Bendotti